Wei Jiang Biography and Net Worth

Director of Waters

Former EVP, President of Pharmaceuticals Region China & Asia Pacific, and President, Bayer Group Greater China Region, Bayer AG

Mr. Jiang is currently an independent director.

With more than 25 years of experience in the pharmaceutical and medical device industries, and particular focus in China and the Asia/Pacific region at large, Mr. Jiang brings an experienced international perspective to the Waters Board.

Mr. Jiang received an M.A. in economics and finance from Indiana State University and a BBA from Campbell University.

What is Wei Jiang's net worth?: The estimated net worth of Wei Jiang is at least $1.02 million as of March 16th, 2026. Mr. Jiang owns 3,441 shares of Waters stock worth more than $1,016,127 as of March 19th. This net worth approximation does not reflect any other assets that Mr. Jiang may own. Learn More about Wei Jiang's net worth.
How do I contact Wei Jiang?: The corporate mailing address for Mr. Jiang and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Wei Jiang's contact information.
Has Wei Jiang been buying or selling shares of Waters?: Over the course of the past ninety days, Wei Jiang has bought $144,730.00 in Waters stock. Most recently, on Monday, March 16th, Wei Jiang bought 500 shares of Waters stock. The stock was acquired at an average cost of $289.46 per share, with a total value of $144,730.00. Following the completion of the transaction, the director now directly owns 3,441 shares of the company's stock, valued at $996,031.86. Learn More on Wei Jiang's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Wei Jiang (Director), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 500 shares worth more than $144,730.00. The most recent insider tranaction occured on March, 16th when Director Wei Jiang bought 500 shares worth more than $144,730.00. Insiders at Waters own 0.6% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 3/16/2026.

Wei Jiang Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/16/2026	Buy	500	$289.46	$144,730.00	3,441

Wei Jiang Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $298.25

$295.06

50 Day Range

MA: $346.42

$283.58

$400.78

2 Week Range

Now: $298.25

$275.05

$414.15

Volume

1,627 shs

Average Volume

1,085,429 shs

Market Capitalization

$29.26 billion

P/E Ratio

27.70

Dividend Yield

N/A

Beta

1.2